Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 232

1.

9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases.

Rajaram V, Leuthardt EC, Singh PK, Ojemann JG, Brat DJ, Prayson RA, Perry A.

Mod Pathol. 2004 Jan;17(1):9-14.

PMID:
14631364
[PubMed - indexed for MEDLINE]
Free Article
2.

Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.

Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A.

Mod Pathol. 2002 May;15(5):526-31.

PMID:
12011257
[PubMed - indexed for MEDLINE]
Free Article
3.

Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.

Rajaram V, Gutmann DH, Prasad SK, Mansur DB, Perry A.

Mod Pathol. 2005 Jul;18(7):991-7.

PMID:
15731777
[PubMed - indexed for MEDLINE]
Free Article
4.

Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization.

Scheil S, Brüderlein S, Eicker M, Herms J, Herold-Mende C, Steiner HH, Barth TF, Möller P.

Brain Pathol. 2001 Apr;11(2):133-43.

PMID:
11303789
[PubMed - indexed for MEDLINE]
5.

Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.

Lamszus K, Lachenmayer L, Heinemann U, Kluwe L, Finckh U, Höppner W, Stavrou D, Fillbrandt R, Westphal M.

Int J Cancer. 2001 Mar 15;91(6):803-8.

PMID:
11275983
[PubMed - indexed for MEDLINE]
6.

Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.

Kraus JA, de Millas W, Sörensen N, Herbold C, Schichor C, Tonn JC, Wiestler OD, von Deimling A, Pietsch T.

Acta Neuropathol. 2001 Jul;102(1):69-74.

PMID:
11547953
[PubMed - indexed for MEDLINE]
7.

Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.

Prayson RA.

Ann Diagn Pathol. 1999 Feb;3(1):11-8.

PMID:
9990108
[PubMed - indexed for MEDLINE]
8.

Molecular staging of intracranial ependymoma in children and adults.

Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Schöttler A, Kulozik AE, Witt O, von Deimling A, Lichter P, Pfister S.

J Clin Oncol. 2010 Jul 1;28(19):3182-90. doi: 10.1200/JCO.2009.27.3359. Epub 2010 Jun 1.

PMID:
20516456
[PubMed - indexed for MEDLINE]
9.

Loss of heterozygosity on chromosome 22 in human ependymomas.

Huang B, Starostik P, Kühl J, Tonn JC, Roggendorf W.

Acta Neuropathol. 2002 Apr;103(4):415-20. Epub 2002 Jan 17.

PMID:
11904762
[PubMed - indexed for MEDLINE]
10.

Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.

Rousseau A, Idbaih A, Ducray F, Crinière E, Fèvre-Montange M, Jouvet A, Delattre JY.

J Neurooncol. 2010 May;97(3):353-64. doi: 10.1007/s11060-009-0039-6. Epub 2009 Oct 29.

PMID:
19865800
[PubMed - indexed for MEDLINE]
11.

Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.

Prayson RA.

Am J Clin Pathol. 1998 Nov;110(5):629-34.

PMID:
9802348
[PubMed - indexed for MEDLINE]
12.

Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index.

Asai A, Hoshino T, Edwards MS, Davis RL.

Childs Nerv Syst. 1992 Aug;8(5):273-8.

PMID:
1394266
[PubMed - indexed for MEDLINE]
13.

Chromosomal imbalances in clear cell ependymomas.

Rickert CH, Korshunov A, Paulus W.

Mod Pathol. 2006 Jul;19(7):958-62. Epub 2006 Apr 28.

PMID:
16648869
[PubMed - indexed for MEDLINE]
Free Article
14.

Molecular analysis of genetic changes in ependymomas.

Bijlsma EK, Voesten AM, Bijleveld EH, Troost D, Westerveld A, Mérel P, Thomas G, Hulsebos TJ.

Genes Chromosomes Cancer. 1995 Aug;13(4):272-7.

PMID:
7547635
[PubMed - indexed for MEDLINE]
15.

Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.

Schneider D, Monoranu CM, Huang B, Rutkowski S, Gerber NU, Krauss J, Puppe B, Roggendorf W.

Cancer Genet Cytogenet. 2009 Jun;191(2):90-6. doi: 10.1016/j.cancergencyto.2009.02.010.

PMID:
19446744
[PubMed - indexed for MEDLINE]
16.

Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients.

Mochizuki S, Iwadate Y, Namba H, Yoshida Y, Yamaura A, Sakiyama S, Tagawa M.

Int J Oncol. 1999 Nov;15(5):983-9.

PMID:
10536183
[PubMed - indexed for MEDLINE]
17.

Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.

Rousseau-Merck M, Versteege I, Zattara-Cannoni H, Figarella D, Lena G, Aurias A, Vagner-Capodano AM.

Cancer Genet Cytogenet. 2000 Sep;121(2):223-7.

PMID:
11063814
[PubMed - indexed for MEDLINE]
18.

Prognostic relevance of localization and grading in intracranial ependymomas of childhood.

Ernestus RI, Schröder R, Stützer H, Klug N.

Childs Nerv Syst. 1996 Sep;12(9):522-6.

PMID:
8906366
[PubMed - indexed for MEDLINE]
19.

Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases.

Preusser M, Hoischen A, Novak K, Czech T, Prayer D, Hainfellner JA, Baumgartner C, Woermann FG, Tuxhorn IE, Pannek HW, Bergmann M, Radlwimmer B, Villagrán R, Weber RG, Hans VH.

Am J Surg Pathol. 2007 Nov;31(11):1709-18.

PMID:
18059228
[PubMed - indexed for MEDLINE]
20.

Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.

von Haken MS, White EC, Daneshvar-Shyesther L, Sih S, Choi E, Kalra R, Cogen PH.

Genes Chromosomes Cancer. 1996 Sep;17(1):37-44.

PMID:
8889505
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk